Creo upbeat on first in-human use of MicroBlate Fine
16th Jun 2021 10:05
(Sharecast News) - Medical device company Creo Medical Group updated the market on its 510(k) US Food and Drug Administration (FDA)-cleared tissue ablation device, 'MicroBlate Fine' on Wednesday, reporting that the device was successfully used for the first in-human, minimally invasive, endoscopic ultrasound (EUS)-guided treatment in a patient with an unresectable pancreatic neuroendocrine tumour.
Read moreCreo Medical buying freehold of current Chepstow headquarters
14th Jun 2021 09:04
(Sharecast News) - Surgical endoscopy-focussed medical device company Creo Medical Group has exchanged contracts to acquire the freehold interest in the current site of its primary headquarters in Chepstow, Creo House, it announced on Monday.
Read moreCreo sales grow, losses widen as company expands
4th Jun 2021 08:58
(Sharecast News) - Surgical endoscopy-focussed medical device company Creo Medical Group reported a "strong" set of final results on Friday, with "significant" internal development and expansion despite the Covid-19 pandemic.
Read moreCreo upbeat on new data around economics of 'Speedboat Inject'
26th May 2021 12:00
(Sharecast News) - Surgical endoscopy medical device company Creo Medical announced on Wednesday that data from a new paper demonstrated that the use of its 'Speedboat Inject' product was "highly likely" to be a cost-effective strategy for treating both benign and malignant large non-pedunculated colorectal polyps (LNPCP).
Read moreCreo Medical ups FY revenues guidance after stronger-than-expected Q1 trading
19th May 2021 09:40
(Sharecast News) - Medical device company Creo Medical Group said on Wednesday that first-quarter trading had been ahead of management expectations, leading the group to upgrade guidance for its year-end revenue performance by "at least 10%".
Read moreCreo Medical ends year 'marginally ahead' of forecasts
17th Feb 2021 09:47
(Sharecast News) - Medical devices company Creo Medical Group said on Wednesday that trading for 2020 was "marginally ahead" of management expectations, with revenue rising to more than £9m, from £0.01m in 2019.
Read moreCreo Medical gets FDA clearance for 'MicroBlate Flex' device
7th Jan 2021 08:09
(Sharecast News) - Surgical endoscopy-focussed medical devices company Creo Medical Group has received 510(k) clearance from the US Food and Drug Administration (FDA) for its 'MicroBlate Flex' tissue ablation device, it announced on Thursday.
Read moreCreo upbeat on first-in-human clinical use of 'MicroBlate Fine'
9th Dec 2020 15:36
(Sharecast News) - Medical device company Creo announced the first in-human clinical use of its 'MicroBlate Fine' device, believed to be the world's smallest fine needle microwave ablation device available for clinical practice.
Read moreCreo Medical acquires Belgian GI consumables supplier Boucart Medical
3rd Nov 2020 08:58
(Sharecast News) - Medical device company Creo Medical said on Tuesday that it had acquired Belgian consumables supplier Boucart Medical as part of a deal worth up to €5.0m.
Read moreCreo Medical acquires European device manufacturer Albyn
24th Jul 2020 09:39
(Sharecast News) - Medical device company Creo Medical Group acquired European manufacturer Albyn Medical on Friday for €24.8m plus as much as €2.7m in performance-related considerations over the next two years.
Read moreCreo Medical gets £2m loan to develop sterilisation technology
2nd Jul 2020 09:42
(Sharecast News) - Medical device company Creo Medical Group has secured a £2m loan from the Cardiff Capital Region project, it announced on Thursday, to develop its 'Cool Plasma' technology as a method to kill bacteria and viruses and for sterilisation purposes.
Read moreCreo gets CE mark for five new devices
15th Jun 2020 16:08
(Sharecast News) - Medical devices company Creo Medical Group announced the simultaneous CE-marking of five new devices on Monday, which form the 'Creo GI' gastrointestinal suite of advanced energy devices across four technology platforms.
Read moreCreo Medical progresses with commercialisation of CROMA
30th Jan 2020 10:50
(Sharecast News) - Medical device company Creo continued to trade in-line with expectations during 2019, while also making progress in the commercialisation of its CROMA Advanced Energy Platform and a suite of patented electrosurgical devices.
Read moreCreo announces first in-human use of 'Speedboat' in India
20th Nov 2019 13:31
(Sharecast News) - Medical device company Creo Medical Group announced on Wednesday that the first mentored, in-human use of its 'Speedboat' device had taken place in India.
Read moreCreo Medical loss widens as commercial launches near
5th Apr 2019 09:11
(Sharecast News) - Creo Medical's shares edged lower on Friday as the company's losses increased on the back of increasing administrative expenses, though it believes it has built a "solid platform for future growth".
Read more